US Stocks
Vaxcyte Inc
Vaxcyte Inc

Vaxcyte Inc (PCVX)


  • $







Key Stats

Today Low/High$22.54 / $22.91
52 Week Low/High$15.51 / $42.32
Market Cap$1.18B

Company Details

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. Vaxcyte’s lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains, including newly emerging strains responsible for IPD and antibiotic resistance; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.
OrganisationVaxcyte Inc
HeadquatersFoster City, California, US
IndustryHealth Technology
CEOGrant Pickering

Discover more

Frequently Asked Questions

What is Vaxcyte Inc (PCVX) share price today?

Can Indians buy Vaxcyte Inc (PCVX) shares?

How can I buy Vaxcyte Inc (PCVX) shares from India?

Can Fractional shares of Vaxcyte Inc (PCVX) be purchased?

What are the documents required to start investing in Vaxcyte Inc (PCVX) stocks?

We are a SEBI registered investement advisor